PNTG · Pennant Group, Inc. · Metrics
$39.00
-1.50 (-3.70%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.42B
Shares
34.93M
Volume · Sep 30
248.73K
Avg daily vol (3M)
317.01K
PNTG metrics
90 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$39.00
Market cap
$1.42B
Price action
20 metricsPrice change (1W)
+2.8%
Price change (30D)
+10.2%
Price change (3M)
+9.6%
Price change (6M)
+32.9%
Price change (YTD)
+43.9%
Price change (1Y)
+60.8%
Trailing year
Price change (5Y)
+36.6%
52-week high
$42.48
52-week low
$23.64
Change from 52-week high
-4.7%
Change from 52-week low
+71.3%
Annualized volatility
37.8%
Annualized volatility (3M)
32.1%
Beta
0.2
RSI (14D)
55.9
Price vs SMA 50
+2.6%
Price vs SMA 200
+18.9%
Avg volume (3M)
318,050
Relative volume
1.0
Average dollar volume
$12.61M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
34.93M
Valuation
12 metricsP / E (TTM)
44.5
Trailing earnings · reciprocal yield 2.2%
PEG ratio
1.8
EV / revenue
1.5×
reciprocal yield 68.6%
EV / EBITDA
22.2×
reciprocal yield 4.5%
EV / EBIT
25.8×
reciprocal yield 3.9%
P / sales
1.3×
reciprocal yield 77.4%
P / book
3.5
reciprocal yield 28.4%
FCF yield
2.4%
TTM · current market cap
Buyback yield
—
P / FCF
41.1
reciprocal yield 2.4%
P / operating cash flow
26.7
reciprocal yield 3.7%
Earnings yield
2.3%
Historical valuation
8 metricsP / E historical average (3Y)
36.7×
reciprocal yield 2.7%
P / E historical average (5Y)
76.4×
reciprocal yield 1.3%
EV / revenue historical average (3Y)
1.2×
reciprocal yield 82.3%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 81.6%
EV / EBIT historical average (3Y)
22.9×
reciprocal yield 4.4%
EV / EBIT historical average (5Y)
39.6×
reciprocal yield 2.5%
EV / EBITDA historical average (3Y)
19.5×
reciprocal yield 5.1%
EV / EBITDA historical average (5Y)
32.8×
reciprocal yield 3.0%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
—
Operating margin
5.6%
Trailing 12 months
Net margin
2.9%
Gross profit (TTM)
—
Operating profit (TTM)
$62.20M
Net income (TTM)
$32.32M
Trailing 12 months
Diluted EPS (TTM)
$0.91
FCF margin
3.1%
Effective tax rate
26.9%
Growth
11 metricsRevenue growth YoY
+35.8%
Year over year
Net income growth YoY
+28.2%
Revenue (TTM)
$1.10B
Trailing 12 months
EPS growth YoY
+25.0%
Shares change YoY
+1.7%
Year over year · more shares
Revenue CAGR (3Y)
+26.0%
Revenue CAGR (5Y)
+19.4%
EPS CAGR (3Y)
+56.3%
EPS CAGR (5Y)
+10.1%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-3.3%
Quality
14 metricsReturn on equity
8.0%
Return on assets
3.1%
Debt / equity
0.5
Current ratio
1.2
EBITDA (TTM)
$72.34M
Free cash flow (TTM)
$34.68M
Quick ratio
1.2
Interest coverage
5.8
Net debt / EBITDA
2.5
Return on invested capital
7.8%
Trailing 12 months
Net cash
−$182.23M
Latest balance sheet
Cash & equivalents
$15.27M
Total assets
$1.04B
Total debt
$197.50M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$53.30M
Capital expenditures (TTM)
$18.62M
R&D (TTM)
—
SG&A (TTM)
$79.94M
Stock compensation (TTM)
$10.08M
R&D / revenue
—
Stock compensation / revenue
0.9%
Ownership (13F)
3 metrics13F filers
203
13F filer change QoQ
+12
Institutional ownership
90.7%
Short interest
3 metricsShort interest
3.0%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
63 / 100
Insider activity
2 metricsNet insider buying (90D)
−$531,946
Insider-sentiment score
38 / 100
Risk flags
1 metricsGoing concern
—